Hos patienter behandlet med rosuvastatin er der set en dosisafhængig øgning i CK niveauer; de fleste tilfælde var milde, asymptomatiske og forbigående.
A dose-related increase in CK levels has been observed in patients taking rosuvastatin; the majority of cases were mild, asymptomatic and transient.